Question 1

Am I eligible for this trial based on my cancer type and previous treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Evaluating Biomarkers in Patients With Colorectal Cancer and Native KRAS Treated With Chemotherapy + Cetuximab clinical trial (NCT01276379). Contact the study team or your healthcare provider for specific answers.

Question 2

What specific benefits might I gain from participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Evaluating Biomarkers in Patients With Colorectal Cancer and Native KRAS Treated With Chemotherapy + Cetuximab clinical trial (NCT01276379). Contact the study team or your healthcare provider for specific answers.

Question 3

How will the treatment in this trial compare to standard treatments I might receive?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Evaluating Biomarkers in Patients With Colorectal Cancer and Native KRAS Treated With Chemotherapy + Cetuximab clinical trial (NCT01276379). Contact the study team or your healthcare provider for specific answers.

Question 4

What are the potential side effects of the chemotherapy and cetuximab?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Evaluating Biomarkers in Patients With Colorectal Cancer and Native KRAS Treated With Chemotherapy + Cetuximab clinical trial (NCT01276379). Contact the study team or your healthcare provider for specific answers.

Question 5

How often will I need to visit the clinic during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Evaluating Biomarkers in Patients With Colorectal Cancer and Native KRAS Treated With Chemotherapy + Cetuximab clinical trial (NCT01276379). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects or complications during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study Evaluating Biomarkers in Patients With Colorectal Cancer and Native KRAS Treated With Chemotherapy + Cetuximab clinical trial (NCT01276379). Contact the study team or your healthcare provider for specific answers.

What this study is about